Meeting
2023 ASCO Annual Meeting
Distributional range of tumor mutational burden (TMB) across multiple cancer types emphasizing the importance of different cutoff values in different tumor types for clinical interpretation: A consensus statement from the SEQUOIA consortium.
Authors
Wojciech Swat
Cancer Genomics and Molecular Pathology, Bioreference Laboratory, Elmwood Park, NJ
Wojciech Swat , Dibyendu Kumar , Theresa A. Boyle , Emily Dalton , Stewart Comer , James Solomon , Shivani Golem , Kenneth R Eyring , Brett Baskovich , Ashutosh Vashisht , Harmanpreet Singh , Pankaj Kumar Ahluwalia , Ahmet Alptekin , Nikhil Sahajpal , Ashis Mondal , Vamsi Kota , Ravindra Kolhe
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Immunotherapy
Track
Developmental Therapeutics—Immunotherapy
Sub Track
Tissue-Based Biomarkers
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 2615)
DOI
10.1200/JCO.2023.41.16_suppl.2615
Abstract #
2615
Poster Bd #
457
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
A plasma-based analysis and genomic landscape of patients with high tumor mutational burden (TMB-H), microsatellite stable (MSS) colorectal cancer (CRC).
First Author: Anwaar Saeed
Poster
2022 ASCO Annual Meeting
Microsatellite-stable tumors with high tumor mutational burden in association with tumor response to immune checkpoint inhibitor therapy across solid tumors and correlation with specific oncogenic alterations.
First Author: Imran Nizamuddin
First Author: Zhiye Zhang
Poster
2021 Gastrointestinal Cancers Symposium
Genomic profiling of gastrointestinal cancers by comprehensive tumor-normal sequencing.
First Author: Fadel S. Alyaqoub